Figures
Tables
Supplementary material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Files in this Data Supplement:
- Supplementary material -
Supplementary Methods
Supplementary Results
Supplementary References
Table E1: Characteristics of lipid-lowering medication users and non-users at baseline
Table E2: Descriptive characteristics of patients with and without MRI data
Table E3: Unadjusted Pearson correlations between obesity and OSA severity measures and natural log transformed lipid measures
Table E4: Covariate comparisons for patients included in and excluded from final propensity score designed cohort
Table E5: Differences in two-year lipid changes between PAP Adherent and non-users within the PS designed cohort
Table E6: Differences in two-year lipid changes between PAP Adherent and Non-users with Abnormal Lipid Levels at Baseline
Table E7: Differences in two-year lipid changes between PAP Adherent and Non-users with percent time SaO2<90 greater than the 75th percentile
Figure E1: Diagram illustrating the analysis sample
- Supplementary material -
Disclosures
Files in this Data Supplement: